Top story
IDEXX (IDXX) Q2 2026: Instruments Drop 20%, Margin Hits 64%
IDEXX sold fewer diagnostic analyzers this quarter — instrument revenue fell 19.5% to $47.2M — and it did not matter, because the installed base did the work in
LineVest Daily
Get this wrap in your inbox every morning.
One email before the U.S. open — the earnings, filings, and guidance changes that matter, in plain English. Free.
Subscribe free